|
|
|
|
Trial | Studied trt | Control trt | patients | tags | ROB | Trial result | All cause death | Death from any cause or hospitalization for heart failure |
---|
|
NSGET (comparative trial), 2000 | nesiritide | control | | | Low risk of bias | remark | | |
NSGET (efficacy trial), 2000 | nesiritide | placebo | | | Low risk of bias | negative | | |
PROACTION, 2003 | nesiritide | placebo | | | Low risk of bias | negative | | |
BNP-CARDS, 2007 NCT | nesiritide | placebo | | | Low risk of bias | remark | | |
FUSION 2, 2008 NCT | nesiritide | placebo | | | Low risk of bias | remark | | |
ASCEND-HF, 2011 NCT | nesiritide | placebo | | | Low risk of bias | negative | | |
VMAC (intravenous neseritide), 2002 NCT | nesiritide | placebo | | | Low risk of bias | remark | | |
PRECEDENT, 2002 NCT | nesiritide | dobutamine | | | Exploratory | remark | | |
VMAC (24h), 2002 NCT | nesiritide | nitroglycerin | | | Risk of bias | negative | | |
FUSION 1, 2004 NCT | nesiritide | standard care | | | Low risk of bias | remark | | |
|
NSGET (comparative trial), 2000 | nesiritide | control | | | Low risk of bias | remark | | |
NSGET (efficacy trial), 2000 | nesiritide | placebo | | | Low risk of bias | negative | | |
PROACTION, 2003 | nesiritide | placebo | | | Low risk of bias | negative | | |
BNP-CARDS, 2007 NCT | nesiritide | placebo | | | Low risk of bias | remark | | |
FUSION 2, 2008 NCT | nesiritide | placebo | | | Low risk of bias | remark | | |
ASCEND-HF, 2011 NCT | nesiritide | placebo | | | Low risk of bias | negative | | |
VMAC (intravenous neseritide), 2002 NCT | nesiritide | placebo | | | Low risk of bias | remark | | |
PRECEDENT, 2002 NCT | nesiritide | dobutamine | | | Exploratory | remark | | |
VMAC (24h), 2002 NCT | nesiritide | nitroglycerin | | | Risk of bias | negative | | |
FUSION 1, 2004 NCT | nesiritide | standard care | | | Low risk of bias | remark | | |
|
PREVENT, 2000 | P-32 | placebo | | | Low risk of bias | suggesting | | |
INHIBIT, 2002 | P-32 | placebo | | | Low risk of bias | suggesting | | |
START, 2000 | P-32 | placebo | | | Low risk of bias | suggesting | | |